During the past decade, Regional GI conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional GI" #1 collaborator was "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator and "Dartmouth College" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Regional GI" are "Colorectal Cancer" (2 trials), "Crohn's Disease" (1 trials), "Inflammatory Bowel Diseases" (1 trials), "Recurrent C. Difficile Infection" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Regional GI" in a lesser frequency.

Most popular intervention types in "Regional GI" are "Other" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Sample Collection" (1 trials), "CP101" (1 trials), "Colonoscopy" (1 trials), "FIT test" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional GI" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Regional GI". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Regional GI, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional GI, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".